When insiders step up and put millions of their own dollars on the line to purchase company stock, investors should take notice. Don’t wait to only then see these stocks on CNBC rocketing up double-digits, buy shares today. After over two decades of successfully investing in the volatile and lucrative small biotech space, I have […]
After record years for deal volume in both 2014 and 2015 in the biotech and pharma industries, M&A transactions have posted a significant decline in the volume of deals so far in 2016 across these industries. As of late August, transactions based on dollar volume were down almost 65% from the same period in 2015. […]
These stocks have serious red flags and are ticking time bombs in your portfolio. Several companies from our 2014 and 2015 watchlists are already bankrupt or very close, and the companies profiled today are likely on the same track. Dump these losers immediately. Bankruptcy is a scary thing but a natural part of the economic […]
Investing is exciting. When you first enter the world of stocks, bonds, real estate, and the limitless other capital investment options, all you can think about is the sheer potential of your financial decisions. Unfortunately, your lack of experience may limit that potential, or sabotage it all together. There’s no way for a novice investor […]
The possibility of a US recession is diminishing, and the Federal Reserve is on track to hike interest rates twice a year for the foreseeable future that’s according to Bank of America Merrill Lynch’s most recent US Credit Investor Survey. Bank of America’s credit survey gives an interesting insight into the world of the bank’s […]
And, that is no exaggeration, these three biotech stocks all have near-term catalysts right around the corner that will send their currently undervalued share prices soaring when positive. Grab shares today because the catalysts we’re targeting for growth start happening in September. One of the keys to investing in the small cap portion of the […]
In August of 1971, Ray Dalio – now one of the most respected hedge fund billionaires on Wall Street – was a lowly clerk working on the Street. By coincidence, Dalio was starting his career during one of history’s critical turning points. President Nixon had just taken the dollar off of the gold standard. Dalio’s […]
“Low interest rates have made it very cheap for companies to grow. Higher ROI will outperform when capital becomes more expensive.” David Poppe, Sequoia Fund’s CEO, on why value stocks have underperformed growth stocks. According to Renaissance Capital, there were 192 biotech IPOs in the past 5 years, raising more than $14.7 billion. Most of […]
In a previous post, I discussed four simple steps to help you create your own investment strategy. The first step was to select the stock screen you want to follow. The second step was to choose how many stocks you will own. Last week’s post went into detail regarding the first step. In this post, […]
Generating investment ideas can be tough. If you’re looking for ways to accomplish this task I wrote a whole article on the subject here, but with this post I want to focus on one way in particular, stock screeners. A stock screener can be an excellent way to generate investment ideas in an objective, unbiased manner. […]
Pick up your pen and paper and write down the names of these four stocks that right now trade for valuations too low for their potential growth. With most stocks tading for premiums right now, finding four growth stocks with attractive valuations to add to your portfolio is worth your attention. I have followed and […]
Free Report!
Simply sign up to receive our FREE Penny Stock Research newsletter and get immediate access to this report!
It's always 100% free and you can unsubscribe at any time.
